Image Source: MLB Trade Rumors
Adam Macko is changing teams at the MLB trade deadline. The Texas Rangers have acquired the left-handed pitcher from the Toronto Blue Jays in a deal that sends infielder Josh Smith and minor league right-hander Josh Stephan to Toronto, according to announcements from both clubs.
The trade was completed on August 3, 2026, and is 40-man roster neutral. Smith and Macko are both on the 40-man roster, while Stephan is not currently included on one.
Adam Macko Trade Gives Rangers Critical Bullpen Depth
Macko, 25, gives Texas another young left-handed option for its bullpen as the Rangers push through a competitive postseason race. The former starter is working primarily as a reliever for the first time this season, providing the organization with additional flexibility during the final stretch.
In 22 major league innings, Macko has posted a 4.91 earned run average, a 23.2 percent strikeout rate and a 10.1 percent walk rate. He has also appeared in 24 1/3 innings at Triple-A this season, recording a 4.07 ERA, a 27.6 percent strikeout rate and a 10.5 percent walk rate.
Although the numbers are not eye-catching, the Rangers appear to be betting on his youth, left-handedness and remaining control. Macko has not yet reached arbitration, which is especially valuable for Texas because the club has limited payroll flexibility.
Why Texas Targeted Macko
The Rangers currently have Jacob Latz working as their closer, leaving Robby Ahlstrom and Tyler Alexander among the primary options for setup work from the left side. Alexander has spent much of his career as a swingman, while Ahlstrom has only limited major league experience.
Macko is not a veteran, but he adds another arm to a bullpen that could benefit from more depth and matchup flexibility. He remains optionable for the rest of the season, allowing Texas to place him directly on the major league roster or continue developing him at Triple-A.
- Macko is 25 years old and has not reached arbitration.
- He owns a 4.91 ERA across 22 major league innings.
- His 2026 role has shifted from starting to relief work.
- The Rangers can control his roster status through the remainder of the season.
Blue Jays Take a Bold Bounceback Chance on Josh Smith
Toronto is acquiring Smith in hopes that his disappointing 2026 campaign is an injury-marred outlier rather than a permanent decline. The 28-year-old was an important utility player for Texas in 2024 and 2025, appearing in 293 games across those two seasons.
During that stretch, Smith hit 23 home runs, stole 23 bases and posted a .254/.336/.380 slash line. FanGraphs credited him with 4.7 wins above replacement, while his 107 wRC+ reflected slightly above-average offensive production.
His 2026 season has been much more difficult. A glute strain sent Smith to the injured list in May, and he was hospitalized with viral meningitis while sidelined. After returning in June, he struggled to regain his form and moved between the majors and Triple-A.
Smith has hit just .213/.299/.272 with one home run in 154 major league plate appearances this year. Still, his defensive versatility remains appealing. He has played every position on the diamond except pitcher and catcher, making him a potentially useful bench piece for the Blue Jays.
Contract Control Adds to Toronto’s Upside
Smith is earning $3.225 million in 2026 and can be retained through arbitration for two additional seasons. Toronto can use the rest of the year to evaluate whether he deserves a modest raise or a regular role in 2027.
If Smith does not show signs of improvement, the Blue Jays could non-tender him after the season. However, his full slate of minor league options gives the club room to keep him in the organization while he works to rebuild his value.
The Blue Jays also surrendered a pitcher who was approaching a roster squeeze. Macko is entering his final option year and will be out of options next season, potentially making him difficult to retain if he did not secure a permanent place in Toronto’s pitching plans.
What the Trade Means for Both Teams
For Texas, the deal is a low-cost attempt to improve bullpen depth without sacrificing a major prospect. Smith had fallen out of the Rangers’ immediate plans, and Stephan was viewed primarily as organizational rotation insurance.
For Toronto, the move is a buy-low opportunity. The Blue Jays receive a versatile position player with two years of arbitration control and hope his previous production returns after a challenging season.
The trade also has longer-term implications. Toronto faces potential rotation uncertainty with Shane Bieber, Max Scherzer and Jameson Taillon all approaching free agency. While Macko was not viewed as a finished product, his departure creates room for the Blue Jays to explore other pitching options behind Dylan Cease, José Soriano and Trey Yesavage.
Ultimately, this is a practical deadline trade rather than a blockbuster. Texas gains an affordable young lefty for its relief corps, while Toronto bets on Smith’s defensive versatility and bounceback potential.
Frequently Asked Questions
Who did the Rangers acquire in the trade?
The Texas Rangers acquired left-handed pitcher Adam Macko from the Toronto Blue Jays.
Who did Toronto receive for Adam Macko?
The Blue Jays received infielder Josh Smith and minor league right-hander Josh Stephan.
How has Adam Macko performed in 2026?
Macko has a 4.91 ERA, a 23.2 percent strikeout rate and a 10.1 percent walk rate over 22 major league innings. He also has a 4.07 ERA in Triple-A.
Why did the Blue Jays trade Adam Macko?
Macko is in his final option year and was potentially nearing a roster squeeze. Toronto chose to exchange him for a controllable utility player with bounceback potential.
What happened to Josh Smith this season?
Smith missed time with a glute strain and was hospitalized with viral meningitis. After returning, he struggled offensively and moved between the majors and Triple-A.
